Cargando…
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972310/ https://www.ncbi.nlm.nih.gov/pubmed/33640038 http://dx.doi.org/10.1016/S0140-6736(21)00501-8 |
| _version_ | 1783666689293942784 |
|---|---|
| author | Manisty, Charlotte Otter, Ashley D Treibel, Thomas A McKnight, Áine Altmann, Daniel M Brooks, Timothy Noursadeghi, Mahdad Boyton, Rosemary J Semper, Amanda Moon, James C |
| author_facet | Manisty, Charlotte Otter, Ashley D Treibel, Thomas A McKnight, Áine Altmann, Daniel M Brooks, Timothy Noursadeghi, Mahdad Boyton, Rosemary J Semper, Amanda Moon, James C |
| author_sort | Manisty, Charlotte |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7972310 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79723102021-03-19 Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals Manisty, Charlotte Otter, Ashley D Treibel, Thomas A McKnight, Áine Altmann, Daniel M Brooks, Timothy Noursadeghi, Mahdad Boyton, Rosemary J Semper, Amanda Moon, James C Lancet Correspondence Elsevier Ltd. 2021 2021-02-25 /pmc/articles/PMC7972310/ /pubmed/33640038 http://dx.doi.org/10.1016/S0140-6736(21)00501-8 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Manisty, Charlotte Otter, Ashley D Treibel, Thomas A McKnight, Áine Altmann, Daniel M Brooks, Timothy Noursadeghi, Mahdad Boyton, Rosemary J Semper, Amanda Moon, James C Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals |
| title | Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals |
| title_full | Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals |
| title_fullStr | Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals |
| title_full_unstemmed | Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals |
| title_short | Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals |
| title_sort | antibody response to first bnt162b2 dose in previously sars-cov-2-infected individuals |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972310/ https://www.ncbi.nlm.nih.gov/pubmed/33640038 http://dx.doi.org/10.1016/S0140-6736(21)00501-8 |
| work_keys_str_mv | AT manistycharlotte antibodyresponsetofirstbnt162b2doseinpreviouslysarscov2infectedindividuals AT otterashleyd antibodyresponsetofirstbnt162b2doseinpreviouslysarscov2infectedindividuals AT treibelthomasa antibodyresponsetofirstbnt162b2doseinpreviouslysarscov2infectedindividuals AT mcknightaine antibodyresponsetofirstbnt162b2doseinpreviouslysarscov2infectedindividuals AT altmanndanielm antibodyresponsetofirstbnt162b2doseinpreviouslysarscov2infectedindividuals AT brookstimothy antibodyresponsetofirstbnt162b2doseinpreviouslysarscov2infectedindividuals AT noursadeghimahdad antibodyresponsetofirstbnt162b2doseinpreviouslysarscov2infectedindividuals AT boytonrosemaryj antibodyresponsetofirstbnt162b2doseinpreviouslysarscov2infectedindividuals AT semperamanda antibodyresponsetofirstbnt162b2doseinpreviouslysarscov2infectedindividuals AT moonjamesc antibodyresponsetofirstbnt162b2doseinpreviouslysarscov2infectedindividuals |